Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• Clostridium difficile infection (CDI) has seen a significant rise globally, both in healthcare settings and the community.
• The emergence of hypervirulent strains has intensified the clinical importance of CDI.
• Current C. difficile strain typing relies on PCR-ribotyping, a method limited to specialized labs and costly.

Purpose of the Study:

• To evaluate MALDI-TOF mass spectrometry as a rapid and cost-effective tool for C. difficile strain typing.
• To establish a database for C. difficile strain identification using MALDI-TOF MS.
• To assess the capability of MALDI-TOF MS in recognizing specific, prevalent C. difficile ribotypes.

Main Methods:

• A comprehensive database was constructed using mass spectra from 25 distinct C. difficile PCR ribotypes analyzed with SARAMIS software.
• The MALDI-TOF MS database was validated using 355 C. difficile strains from 29 different PCR ribotypes collected prospectively.
• Spectra analysis focused on identifying unique markers for specific ribotypes.

Main Results:

• MALDI-TOF MS successfully recognized the most frequent C. difficile ribotypes: type 001 (70%), 027 (4.8%), and 078/126 (4.7%).
• The validated system demonstrated accuracy in identifying these prevalent strains.
• Specific spectral markers were identified for key ribotypes, confirming the method's discriminatory power.

Conclusions:

• An extended MALDI-TOF MS system is a viable and effective method for identifying specific C. difficile ribotypes.
• This technique offers a faster and potentially more accessible alternative to PCR-ribotyping for CDI surveillance.
• MALDI-TOF MS can aid in the rapid identification of hypervirulent C. difficile strains, improving infection control efforts.